| dc.contributor.author | Smith, SJ | |
| dc.contributor.author | Busby, J | |
| dc.contributor.author | Heaney, LG | |
| dc.contributor.author | Pfeffer, PE | |
| dc.contributor.author | Jackson, DJ | |
| dc.contributor.author | Yang, F | |
| dc.contributor.author | Fowler, SJ | |
| dc.contributor.author | Menzies-Gow, A | |
| dc.contributor.author | Idris, E | |
| dc.contributor.author | Brown, T | |
| dc.contributor.author | Gore, R | |
| dc.contributor.author | Faruqi, S | |
| dc.contributor.author | Dennison, P | |
| dc.contributor.author | Dodd, JW | |
| dc.contributor.author | Doe, S | |
| dc.contributor.author | Mansur, AH | |
| dc.contributor.author | Priyadarshi, R | |
| dc.contributor.author | Holmes, J | |
| dc.contributor.author | Hearn, A | |
| dc.contributor.author | Al-Aqqad, H | |
| dc.contributor.author | Loewenthal, L | |
| dc.contributor.author | Cooper, A | |
| dc.contributor.author | Fox, L | |
| dc.contributor.author | Selvan, M | |
| dc.contributor.author | Crooks, MG | |
| dc.contributor.author | Thompson, A | |
| dc.contributor.author | Higbee, D | |
| dc.contributor.author | Fawdon, M | |
| dc.contributor.author | Nathwani, V | |
| dc.contributor.author | Holmes, L | |
| dc.contributor.author | Chaudhuri, R | |
| dc.date.accessioned | 2021-03-26T14:37:11Z | |
| dc.date.available | 2020-10-23 | |
| dc.date.available | 2021-03-26T14:37:11Z | |
| dc.date.issued | 2021-01 | |
| dc.identifier.issn | 2312-0541 | |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/70900 | |
| dc.description.abstract | Asthma therapy, including monoclonal antibodies, was not associated with #COVID19 infection or hospitalisation in a UK severe asthma population. Shielding led to a reported worsening of mental health in nearly half of patients contacted (47%). https://bit.ly/3jImUsG. | en_US |
| dc.language | eng | |
| dc.relation.ispartof | ERJ Open Res | |
| dc.rights | Creative Commons Attribution Non-Commercial Licence 4.0 | |
| dc.title | The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown? | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1183/23120541.00768-2020 | |
| pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/33564672 | en_US |
| pubs.issue | 1 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published online | en_US |
| pubs.volume | 7 | en_US |
| dcterms.dateAccepted | 2020-10-23 | |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
